[HTML][HTML] Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
B Shebl, D Ng, G Lalazar, C Rosemore… - JCI insight, 2022 - ncbi.nlm.nih.gov
Fibrolamellar hepatocellular carcinoma (FLC) is a rare and often lethal liver cancer with no
proven effective systemic therapy. Inhibition of the antiapoptotic protein BCL-XL was found …
proven effective systemic therapy. Inhibition of the antiapoptotic protein BCL-XL was found …
Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
B Shebl, D Ng, G Lalazar, C Rosemore… - JCI …, 2022 - scholars.uthscsa.edu
Fibrolamellar hepatocellular carcinoma (FLC) is a rare and often lethal liver cancer with no
proven effective systemic therapy. Inhibition of the antiapoptotic protein BCL-XL was found …
proven effective systemic therapy. Inhibition of the antiapoptotic protein BCL-XL was found …
[PDF][PDF] Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
B Shebl, D Ng, G Lalazar, C Rosemore… - …, 2022 - pdfs.semanticscholar.org
Fibrolamellar hepatocellular carcinoma (FLC) is a rare and often lethal primary liver cancer
of adolescents and young adults (1, 2). Surgical resection is the current standard of care for …
of adolescents and young adults (1, 2). Surgical resection is the current standard of care for …
Targeting BCL-XL in fibrolamellar hepatocellular carcinoma.
B Shebl, D Ng, G Lalazar, C Rosemore, TM Finkelstein… - JCI Insight, 2022 - europepmc.org
Fibrolamellar hepatocellular carcinoma (FLC) is a rare and often lethal liver cancer with no
proven effective systemic therapy. Inhibition of the antiapoptotic protein BCL-XL was found …
proven effective systemic therapy. Inhibition of the antiapoptotic protein BCL-XL was found …
Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
B Shebl, D Ng, G Lalazar, C Rosemore… - JCI …, 2022 - pubmed.ncbi.nlm.nih.gov
Fibrolamellar hepatocellular carcinoma (FLC) is a rare and often lethal liver cancer with no
proven effective systemic therapy. Inhibition of the antiapoptotic protein BCL-XL was found …
proven effective systemic therapy. Inhibition of the antiapoptotic protein BCL-XL was found …
Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
B Shebl, D Ng, G Lalazar, C Rosemore… - JCI …, 2022 - pure.johnshopkins.edu
Fibrolamellar hepatocellular carcinoma (FLC) is a rare and often lethal liver cancer with no
proven effective systemic therapy. Inhibition of the antiapoptotic protein BCL-XL was found …
proven effective systemic therapy. Inhibition of the antiapoptotic protein BCL-XL was found …
Targeting Bcl-xL in fibrolamellar hepatocellular carcinoma
B Shebl, G Lalazar, D Ng, T Finkelstein, G Zheng… - Cancer Research, 2022 - AACR
Fibrolamellar hepatocellular carcinoma (FLC) is a lethal pediatric cancer affecting
adolescents and young adults. Besides surgical resection, there is no approved and …
adolescents and young adults. Besides surgical resection, there is no approved and …
[HTML][HTML] Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
B Shebl, D Ng, G Lalazar, C Rosemore… - JCI …, 2022 - Am Soc Clin Investig
JCI Insight - Targeting BCL-XL in fibrolamellar hepatocellular carcinoma Go to The Journal of
Clinical Investigation About Editors Consulting Editors For authors Publication ethics Publication …
Clinical Investigation About Editors Consulting Editors For authors Publication ethics Publication …
[HTML][HTML] Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
B Shebl, D Ng, G Lalazar, C Rosemore… - JCI …, 2022 - Am Soc Clin Investig
JCI Insight - Targeting BCL-XL in fibrolamellar hepatocellular carcinoma Go to The Journal of
Clinical Investigation About Editors Consulting Editors For authors Publication ethics Transfers …
Clinical Investigation About Editors Consulting Editors For authors Publication ethics Transfers …
Targeting BCL-XL in fibrolamellar hepatocellular carcinoma.
B Shebl, D Ng, G Lalazar, C Rosemore, TM Finkelstein… - JCI Insight, 2022 - europepmc.org
Fibrolamellar hepatocellular carcinoma (FLC) is a rare and often lethal liver cancer with no
proven effective systemic therapy. Inhibition of the antiapoptotic protein BCL-XL was found …
proven effective systemic therapy. Inhibition of the antiapoptotic protein BCL-XL was found …